Find Clinical Trials & Studies

Treatment Study for Active Ulcerative Colitis

I'm Interested!
Please call
1-833-78TRIAL

An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects with Moderately to Severely Active Ulcerative Colitis

  • Sex: Any
  • Age: Child (Birth - 17)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase II
  • Conditions Being Studied: Ulcerative Colitis

Study Purpose

The purpose of this study is to assess an investigational drug called etrasimod (also referred to as the “study drug”) in the treatment of moderately to severely active ulcerative colitis.

Who Can Participate

Age: 12-18

Principal Investigator
Thomas Sferra MD
Department/Division
Pediatrics (Gastroenterology)

Locations

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106

UH Rainbow Babies & Children’s Ahuja Center for Women & Children
5805 Euclid Ave
Cleveland OH, 44103

UH Westlake Health Center
960 Clague Rd
Westlake OH, 44145

  • UH IRB: STUDY20220204
  • StudyID: 2022-0884
  • ClinicalTrials.gov: NCT05287126
I'm Interested!
Please call
1-833-78TRIAL

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL

Cancer Trials: 1-866-373-1464